je.st
news
Home
› Alzheimer's Drug Discovery Foundation Awards Grant To CohBar To Develop A Novel Peptide Therapeutic For Alzheimer's Disease
Alzheimer's Drug Discovery Foundation Awards Grant To CohBar To Develop A Novel Peptide Therapeutic For Alzheimer's Disease
2013-04-03 03:33:52| drugdiscoveryonline News Articles
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded$205,260in funding to CohBar Inc. to develop a novel mitochondrial peptide for the treatment of Alzheimer's disease (AD)
Tags: develop
foundation
drug
awards
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|